Investigations

CHPT SHAREHOLDER ALERT: Johnson Fistel Investigates ChargePoint Shareholder rights law firm Johnson Fistel, LLP is investigating whether ChargePoint Holdings Inc (“ChargePoint” or the “Company”) (NYSE: CHPT), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased ChargePoint securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On November 17, 2023, said revenue slumped to $108 million to $113 million for the quarter that ended last month, down from a year ago and well short of its guidance for at least $150 million. Pasquale Romano, who had

POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price? Stakeholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. (“POINT”) (NASDAQ: PNT) breached their fiduciary duties in connection with the proposed sale of the Company to Eli Lilly and Company. On October 3, 2023, POINT announced that it had entered a deal with Eli Lilly and Company. Under the terms of this agreement, stakeholders will receive $12.50 per share in an all-cash offer. The investigation concerns whether the POINT board failed to satisfy its duties to the Company stakeholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for POINT shares of common stock especially considering the company has a price target of $27.00 from one analyst. If you are a stakeholder of

Inspired Entertainment Investigation Alert: Shareholders Are Encouraged to Contact Johnson Fistel for Their Options Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Inspired Entertainment, Inc. (NASDAQ: INSE), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information amp investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Inspired Entertainment securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On November 8, 2023,Inspired Entertainment, a gaming technology company, disclosed that the company did not comply with Generally Accepted Accounting Principles pertaining to the capitalization of its software. Along with this, the company announced that

AMPL SHAREHOLDER ALERT: Johnson Fistel Investigates Amplitude Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Amplitude, Inc. (NASDAQ: AMPL), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Amplitude securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent

EAF SHAREHOLDER ALERT: Johnson Fistel Investigates GrafTech Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether GrafTech International Ltd. (“GrafTech” or the “Company”) (NYSE: EAF), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased GrafTech securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? GrafTech, a graphite electrode manufacturer, announced on September 16, 2022, that its operations at the manufacturing facility in Nuevo León, Mexico, had been temporarily suspended after an inspection by the State Attorney’s Office for the Secretary of the Environment.

SPWR SHAREHOLDER ALERT: Johnson Fistel Investigates SunPower SAN DIEGO, October 25, 2023 (GLOBE NEWSWIRE)–Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether SunPower Corporation (NASDAQ: SPWR), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased SunPower securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On October 25, 2023, SunPower stock plummeted by 20% in early market trading after the Company disclosed it will restate its year-end 2022 10-K and 2023 Q1 and Q2 financial statements, saying it found material weakness in its

HRL SHAREHOLDER ALERT: Johnson Fistel Investigates Hormel Foods.   Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Hormel Foods Corporation (NYSE: HRL), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Hormel securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On October 12, 2023, Hormel Foods Corp.’s stock plummeted by 8% to $33.11 per share after union workers ratified a new contract with the largest wage increases in company history. What if I have relevant nonpublic information? Individuals with nonpublic information

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of EngageSmart to Vista Equity. Is $23.00 a Fair Price? Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of EngageSmart, Inc. (NYSE: ESMT) (“EngageSmart” or “the Company”) breached their fiduciary duties in connection with the proposed sale of the Company by an affiliate of Vista Equity Partners (“Vista”). On October 23, 2023, EngageSmart announced that it had entered a deal to merge with Vista. Under the terms of the deal, EngageSmart shareholders will receive $23.00 per share in an all-cash offer. Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one analyst’s price target is currently $40.00. The investigation concerns whether the EngageSmart board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of LiveVox to NICE Systems Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of LiveVox Holdings, Inc. (“LiveVox”) (NASDAQ: LVOX) breached their fiduciary duties in connection with the proposed sale of the Company to NICE Systems. On October 4, 2023, LiveVox announced that it had entered a deal to merge with NICE Systems. Under the terms of the deal, LiveVox shareholders will receive $3.74 per share in an all-cash offer. The transaction is anticipated to conclude within the first half of 2024. Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially since the average analysts’ price target is currently $3.93. The investigation concerns whether the LiveVox board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Startek to Capital Square Partners Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Startek, Inc. (“Startek” or “the Company”) (NYSE: SRT) breached their fiduciary duties in connection with the proposed sale of the Company to Capital Square Partners (“CSP”). On October 10, 2023, Startek announced that it had entered a deal to merge with CSP. Under the terms of the deal, Startek shareholders will receive $4.30 per share in an all-cash offer. The transaction is anticipated to conclude by the end of the calendar year 2023, provided that all customary closing conditions are met. The transaction is not contingent on any financing arrangements. Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially since the average analysts’ price target is currently $4.90. The investigation concerns whether the Startek board failed to

KVUE Shareholder Update: Johnson Fistel Encourages Kenvue Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline Johnson Fistel, LLP notifies investors of Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE) that a securities class action lawsuit has been filed. The lawsuit seeks to recover losses on behalf of investors who acquired securities (pursuant to the registration statement and related prospectus issued in connection with Kenvue’s initial public offering (“IPO”). Investors have until December 8, 2023, to apply to the Court to be appointed as lead plaintiff in the lawsuit. There is no cost or obligation to you. Complaint Allegations: The lawsuit alleges that, in the IPO documents, Defendants made false and/or misleading statements, as well as failed to disclose that: (i) Kenvue faces potential headwinds as a result of confirmed concerns about the efficacy of phenylephrine, which it knew or should have known; (ii) Kenvue did not discuss risks

Consolidated Communications (CNSL) News: Johnson Fistel Investigates Proposed Sale; Is $4.70 a Fair Price? Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Consolidated Communications (NASDAQ: CNSL) breached their fiduciary duties in connection with the proposed sale of the Company to affiliates of Searchlight Capital Partners and British Columbia Investment Management. On October 16, 2023, Consolidated Communications announced that it had entered a deal with Searchlight Capital Partners and British Columbia Investment Management. Under the terms of this agreement, shareholders will receive $4.70 per share in an all-cash offer. The investigation concerns whether the Consolidated Communications board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Consolidated Communications shares of common stock. If you are a shareholder of Consolidated Communications and believe

Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic Holding, Inc. (NASDAQ: MORF), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Morhpic securities? If you purchased securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. In September of 2023,

GCT Shareholder Update: Johnson Fistel Encourages GigaCloud Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline Johnson Fistel, LLP notifies investors of GigaCloud Technology Inc. (“GigaCloud” or the “Company”) (NASDAQ: GCT) a securities class action lawsuit has been filed. The lawsuit seeks to recover losses on behalf of investors who acquired (a) Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); and/or (b) securities between August 18, 2022 and September 27, 2023, both dates inclusive (the “Class Period”). Investors have until December 4, 2023, to apply to the Court to be appointed as lead plaintiff in the lawsuit. There is no cost or obligation to you. Complaint Allegations: The complaint filed in this class action alleges that in the Registration Statement and throughout the Class Period,

SILK SHAREHOLDER ALERT: Johnson Fistel Encourages Silk Road Medical Shareholders with Losses to Contact the Firm Regarding Investigation Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Silk Road Medical, Inc (NASDAQ: SILK), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Silk Road Medical securities? If you purchased Silk Road Medical securities and suffered significant losses on your investment, join our investigation now: Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On October 10, 2023, the company missed Wall Street’s expectations and reduced full-year guidance of $170 million to $174 million from a prior range of $180

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Pioneer Natural Resources to Exon Mobil San Diego – GlobeNewswire—October 11, 2023 Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Pioneer Natural Resources Company (NYSE: PXD) (“Pioneer”) breached their fiduciary duties in connection with the proposed sale of the Company to Exon Mobil (NYSE: XOM). On October 11, 2023, Pioneer announced that it had entered a deal to be purchased by Exon Mobil. Under the terms of the deal, Pioneer shareholders will receive 2.3234 Exxon shares for each Pioneer share they own. The companies said that based on the October 5 closing prices of $108.99 for Exxon’s stock and $214.96 for Pioneer’s stock, the deal values Pioneer shares at $253.23. Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially since the average analysts’ price target is currently $263. The investigation

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Merger of Westrock and Smurfit Kappa Group Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Westrock Co. (NYSE: WRK) breached their fiduciary duties in connection with the proposed merger of the Company and Smurfit Kappa Group Plc (OTC: SMFKY). On July 12, 2023, WestRock announced that it had entered a deal to merge with Smurfit Kappa. Under the terms of the deal, WestRock shareholders will receive one Smurfit WestRock share and $5 cash, equivalent to $43.51 per share, while Smurfit Kappa shareholders will receive one new share. If you are a shareholder of WestRock and believe the proposed buyout price is too low or you’re interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number. About Johnson Fistel, LLP:Johnson Fistel, LLP is a

MGM Resorts Shareholder News: Johnson Fistel Encourages MGM Resorts Shareholders with Losses to Contact the Firm Regarding Investigation Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether MGM Resorts International (“MGM” or “the Company”) (NYSE: MGM), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased MGM common stock? If you purchased MGM common stock and suffered significant losses on your investment, join our investigation now: For more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On October 5, 2023, MGM disclosed that the cyber security issue that occurred in September is estimated to negatively affect Adjusted Property EBITDAR by $100 million.

Enerflex Shareholder News: Johnson Fistel Encourages Enerflex Shareholders with Losses to Contact the Firm Regarding Investigation Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Enerflex Ltd. (“Enerflex” or the “Company”) (NYSE: EFXT), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Enerflex common stock? If you purchased Enerflex common stock and suffered significant losses on your investment, join our investigation now: For more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471 There is no cost or obligation to you. What is Johnson Fistel investigating? On October 2, 2023, Enerflex announced that Rodney D. Gray had resigned from his role as Senior Vice President and Chief Financial Officer. Following the news Enerflex stock was

Investigation Alert IBRX: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below Johnson Fistel, LLP is investigating potential claims on behalf of ImmunityBio, Inc. (NASDAQ: IBRX) against certain of its officers and directors. If you are a current, long-term shareholder of ImmunityBio, continuously holding shares since May 23, 2022, you may have standing to hold the company harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing. You can submit your information below to join this action: Recently a class action complaint was filed against the company. The filed complaint alleges that defendants made false statements and/or concealed that: (i) ImmunityBio conducted insufficient due diligence to discover, or else did discover and ignored, Good Manufacturing Practice (“GMP”) deficiencies at its third-party contract manufacturing organizations